Showing results (171-180 of 279) with videos related to
Sort By:
Pageof 28
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
Digital image analysis outperforms manual biomarker assessment in breast cancerGustav Stålhammar, Nelson Fuentes Martinez, Michael Lippert, et al.Acta Oncologica (Stockholm, Sweden)|August 28, 2002
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in SwedenJenny Andersson, Barbro Linderholm, Gudrun Greim, et al.Scientific Reports|December 1, 2016
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkersMattias Rantalainen, Daniel Klevebring, Johan Lindberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Feasibility of [89Zr]Zr-Atezolizumab Immuno-PET for PD-L1 Quantification in the Clinical Work-up of Metastatic Triple-Negative Breast CancerJoni J Nijveldt, Siri Af Burén, Thuy A Tran, et al.The Oncologist|June 15, 2014
The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for human useHector Boix-Perales, Jeanett Borregaard, Kristina Bech Jensen, et al.The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.Archives of Gynecology and Obstetrics|November 6, 2013
Breakthroughs in research and treatment of early breast cancer: an overview of the last three decadesManfred Kaufmann, Gunter von Minckwitz, Jonas Bergh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA studyMichael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancerBent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen, et al.Pageof 28